Symbiotec Pharmalab IPO Review

Symbiotec Pharmalab Limited, a company with a strong global leadership position in Corticosteroid and Steroidal Hormone Active Pharmaceutical Ingredients, plans to raise INR 1,757 crore through an IPO. [Fresh Issue ₹150 Cr + OFS ₹1,607 Cr] Symbiotec Pharmalab IPO price: ₹938–₹988 per share   Symbiotec Pharmalab: History The Company was incorporated as Symbiotec Pharmalab Private… Continue reading Symbiotec Pharmalab IPO Review

Anlon Healthcare IPO – Review

Anlon Healthcare Limited, a research-intensive manufacturer of Pharmaceutical Intermediates and Active Pharmaceutical Ingredients, plans to raise ₹121 Crore through an IPO. [Fresh Issue ₹ 121 Cr + OFS NIL] Anlon healthcare ipo price is ₹ 86 – ₹ 91 per share   Anlon Healthcare: History The Company was originally incorporated as Anlon Ventures Private Limited,… Continue reading Anlon Healthcare IPO – Review

Ipca Laboratories Limited: Value Pick Stock April 2020

Ipca Laboratories Limited (IPCA) is a fully-integrated Indian pharmaceutical company manufacturing and marketing over 350 formulations and 80 Active Pharmaceutical Ingredients (APIs) covering various therapeutic segments. Ipca Laboratories Limited: Profile Ipca Laboratories was founded by a group of businessmen and medical professionals in the year 1949 under the name of The Indian Pharmaceutical Combine Association… Continue reading Ipca Laboratories Limited: Value Pick Stock April 2020

Exit mobile version